Adenocarcinoma, Renal

Adenocarcinoma, Renal is the indication for 5 drugs in DrugBank. It is covered by 8 curated, structured indications.

Also known as: Carcinoma, Renal Cell · Renal Cell Carcinoma · Renal Cell Cancer · Adenocarcinoma, Renal Cell · Renal Cell Carcinoma (RCC)
Classified under: Neoplasms
Urogenital Diseases
Indicated drugs: Belzutifan
Interferon alfa
Pembrolizumab
Sunitinib
Tivozanib

Resolves to

Vocabularies

MeSHM0003442SNOMED CT1187306007MedDRA10001174UMLSC0007134

What you can answer from here — as of October 22, 2026

5Indicated drugsWith each drug's targets and mechanism

Listed above

8Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

1,534Clinical trialsPhase, status and sponsor resolved per trial

8Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Adenocarcinoma, Renal share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.